Authorization of genetically modified maize DP23211 on the European market

The European Parliament analyzes the European Commission's decision to authorize the marketing of genetically modified maize DP23211. This decision came after a complex evaluation process despite objections from member states. The adopted text examines the implications of this authorization for agriculture, environment, and public health.

Context and objectives

The legal basis is Regulation (EC) No 1829/2003 on genetically modified food and feed. The procedure began in December 2019 when Pioneer Overseas Corporation submitted the authorization application. The European Food Safety Authority (EFSA) issued a favorable opinion in November 2023, and the European Commission authorized the product in July 2024.

Key measures

• Authorization of genetically modified maize DP23211 marketing for food and feed
• Exclusion of cultivation of this maize in European Union territory
• Implementation of a monitoring plan to track effects
• Compliance with risk assessment procedures for environment and health
• Ensuring transparency in the authorization process
• Consultation with member states and stakeholders

Timeline and implementation

Implementing Decision (EU) 2024/1826 entered into force on July 2, 2024. The European Commission is responsible for implementation, in cooperation with member states. The Standing Committee on Plants, Animals, Food and Feed and the Appeal Committee failed to adopt a common position, allowing the Commission to proceed with authorization.

Impact for citizens and stakeholders

The authorization affects food producers, farmers, and consumers. The maize contains genes conferring resistance to glufosinate and produces insecticidal proteins. There are concerns about effects on biodiversity, soil health, and water quality. The authorization process has been criticized for lack of majority support from member states.